YU66099A - Transdermalni sistem za davanje lekova i upotreba terapeutskih smeša u proizvodnji lekova za lečenje virusnih i mikrobskih infekcija i štetnih sindroma - Google Patents

Transdermalni sistem za davanje lekova i upotreba terapeutskih smeša u proizvodnji lekova za lečenje virusnih i mikrobskih infekcija i štetnih sindroma

Info

Publication number
YU66099A
YU66099A YU66099A YU66099A YU66099A YU 66099 A YU66099 A YU 66099A YU 66099 A YU66099 A YU 66099A YU 66099 A YU66099 A YU 66099A YU 66099 A YU66099 A YU 66099A
Authority
YU
Yugoslavia
Prior art keywords
treatment
medicaments
syndromes
infections
virus
Prior art date
Application number
YU66099A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Michelle Olga Patricia Visser
Original Assignee
Virodene Pharmaceutical Holdings (Proprietary) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Virodene Pharmaceutical Holdings (Proprietary) Limited filed Critical Virodene Pharmaceutical Holdings (Proprietary) Limited
Publication of YU66099A publication Critical patent/YU66099A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
YU66099A 1997-06-13 1998-06-09 Transdermalni sistem za davanje lekova i upotreba terapeutskih smeša u proizvodnji lekova za lečenje virusnih i mikrobskih infekcija i štetnih sindroma YU66099A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
YU66099A true YU66099A (sh) 2002-10-18

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
YU66099A YU66099A (sh) 1997-06-13 1998-06-09 Transdermalni sistem za davanje lekova i upotreba terapeutskih smeša u proizvodnji lekova za lečenje virusnih i mikrobskih infekcija i štetnih sindroma

Country Status (34)

Country Link
EP (1) EP1011567A4 (id)
JP (1) JP4531141B2 (id)
KR (1) KR20010013709A (id)
CN (1) CN1260703A (id)
AP (1) AP1629A (id)
AR (1) AR012970A1 (id)
AU (1) AU7831598A (id)
BG (1) BG103997A (id)
BR (1) BR9810095A (id)
CA (1) CA2295176A1 (id)
CZ (1) CZ298510B6 (id)
EA (1) EA200000011A1 (id)
EE (1) EE9900562A (id)
ES (1) ES2161187B1 (id)
FI (1) FI19992648L (id)
GB (1) GB2341319B (id)
HU (1) HUP0003034A2 (id)
ID (1) ID23516A (id)
IL (2) IL133396A0 (id)
IS (1) IS5289A (id)
LT (1) LT4714B (id)
LV (1) LV12490B (id)
NO (1) NO996117L (id)
NZ (1) NZ501669A (id)
OA (1) OA11307A (id)
PL (1) PL196256B1 (id)
RO (1) RO121252B1 (id)
SI (1) SI20191A (id)
SK (1) SK172299A3 (id)
TN (1) TNSN98086A1 (id)
TR (1) TR200000540T2 (id)
WO (1) WO1998056325A1 (id)
YU (1) YU66099A (id)
ZA (1) ZA984649B (id)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1638468T3 (pl) * 2003-06-30 2008-01-31 Alza Corp Sposób powlekania mikrowystępów do przekłuwania skóry
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
ES2115756T3 (es) * 1992-02-20 1998-07-01 Merrell Pharma Inc Derivados de acido sulfonico utilizados en el tratamiento de enfermedades virales.
GEP20012423B (en) * 1995-12-15 2001-05-25 Cryopreservation Tech Cc Composition for Organ Cryopreservation and Treatment of Viral and Bacterial Infections

Also Published As

Publication number Publication date
IS5289A (is) 1999-12-08
TNSN98086A1 (fr) 2005-03-15
GB2341319B (en) 2002-02-27
WO1998056325A1 (en) 1998-12-17
LT4714B (lt) 2000-10-25
JP4531141B2 (ja) 2010-08-25
JP2002511862A (ja) 2002-04-16
IL133396A0 (en) 2001-04-30
AP9901708A0 (en) 1999-12-31
NO996117D0 (no) 1999-12-10
BR9810095A (pt) 2001-11-13
FI19992648A7 (fi) 2000-02-03
AU7831598A (en) 1998-12-30
ES2161187A1 (es) 2001-11-16
NZ501669A (en) 2001-09-28
SK172299A3 (en) 2000-09-12
FI19992648L (fi) 2000-02-03
EE9900562A (et) 2000-06-15
CA2295176A1 (en) 1998-12-17
GB2341319A (en) 2000-03-15
GB9929189D0 (en) 2000-02-02
AR012970A1 (es) 2000-11-22
IL133396A (en) 2006-10-05
AP1629A (en) 2006-07-11
LV12490B (en) 2000-12-20
ID23516A (id) 2000-04-27
ZA984649B (en) 1999-12-17
EP1011567A1 (en) 2000-06-28
EP1011567A4 (en) 2000-06-28
CN1260703A (zh) 2000-07-19
TR200000540T2 (tr) 2000-09-21
LT99148A (lt) 2000-07-25
PL196256B1 (pl) 2007-12-31
SI20191A (sl) 2000-10-31
CZ298510B6 (cs) 2007-10-24
HUP0003034A2 (hu) 2000-12-28
LV12490A (en) 2000-06-20
ES2161187B1 (es) 2003-08-16
KR20010013709A (ko) 2001-02-26
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
CZ9904473A3 (cs) 2001-03-14
EA200000011A1 (ru) 2000-08-28
NO996117L (no) 2000-02-11
BG103997A (bg) 2001-07-31
PL338439A1 (en) 2000-11-06

Similar Documents

Publication Publication Date Title
DK1079806T3 (da) Præparater til påföringen af antiinflammatoriske, især antiseptiske midler og/eller midler, der fremmer helingen af sår, til de övre luftveje og/eller öret
BR9810745A (pt) Derivados de benzimidazol
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
BR0316397A (pt) Tiouréias aril substituìdas e compostos relacionados como inibidores de replicação viral
FI964452A7 (fi) Atsitromysiinin kontrolloidun vapautumisen annostusmuotoja
ATE399562T1 (de) Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
MX2022006742A (es) Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
CO4520283A1 (es) Agentes antivirales
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
AP9801286A0 (en) Therapeutic compounds.
YU66099A (sh) Transdermalni sistem za davanje lekova i upotreba terapeutskih smeša u proizvodnji lekova za lečenje virusnih i mikrobskih infekcija i štetnih sindroma
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
RU2149007C1 (ru) Антипаразитарная, антимикробная противовоспалительная мазь пролонгированного действия
RU2141819C1 (ru) Мазь с интерфероном человеческим лейкоцитарным "интерон"
KR100227125B1 (ko) 미포자충감염을치료하기위한벤즈이미다졸구충제의용도
KR20230066356A (ko) 바이러스 감염 예방 복합제제 및 이의 제조/사용 방법과 용도
RU2702124C2 (ru) Способ профилактики и терапии отодектоза плотоядных животных и псороптоза кроликов
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
BG100835A (bg) Ново лекарствено средство за лечение на вирусни инфекции на дихателните пътища
RU2702123C2 (ru) Способ профилактики и терапии отодектоза плотоядных животных и псороптоза кроликов
JPS63270627A (ja) 免疫用薬剤
RU2306923C1 (ru) Способ лечения отодектоза у кошек
RU2306149C2 (ru) Способ лечения больных с затяжной пневмонией с применением препарата "рузам"